Medicine by Design is investing $600,000 in four emerging researchers at the University of Toronto (U of T) and its affiliated hospitals whose work could advance treatments for a wide range of diseases and conditions including cancer, Alzheimer’s disease, autism and aneurysm.
The Post-Doctoral Fellowship Awards, which Medicine by Design grants annually through a competitive process, support post-doctoral fellows who have the potential to become leaders in regenerative medicine.
“Medicine by Design is proud to support these outstanding new researchers,” says Michael Sefton, executive director of Medicine by Design, and a University Professor at the Institute of Biomedical Engineering and the Department of Chemical Engineering & Applied Chemistry at U of T. “Through the Post-Doctoral Fellowship Awards, we are committed to advancing their innovative and high-impact work and their career development, ensuring they are well positioned to lead regenerative medicine into the future.”
Medicine by Design’s Post-Doctoral Fellowship Awards have been offered annually since 2016. The 2020 awardees will receive $75,000 per year for two years. This year’s recipients work in laboratories at U of T, University Health Network and The Hospital for Sick Children, and have specializations in cell biology, molecular biology, genetics, biophysics and mechanical and industrial engineering.
Meet this year’s award recipients
About Medicine by Design
Medicine by Design builds on decades of made-in-Canada excellence in regenerative medicine. Regenerative medicine uses stem cells to replace diseased tissues and organs, creating therapies in which cells are the biological product. It can also mean triggering stem cells that are already present in the human body to repair damaged tissues or to modulate immune responses. Increasingly, regenerative medicine researchers are using a stem cell lens to identify critical interactions or defects that prepare the ground for disease, paving the way for new approaches to preventing disease before it starts.
Medicine by Design is made possible thanks in part to a $114-million grant from the Canada First Research Excellence Fund.